Inventor · disambiguated record
Thomas J. Kipps
Also filed as: KIPPS THOMAS · KIPPS THOMAS J · KIPPS THOMAS JAMES
36 granted patents·15 pending applications·352 citations·filing 1997–2024
97Inventor score
Top patents by PatentIndex Score
51 records- 0195US11312787B2Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasisUNIV CALIFORNIA·Filed 2019·Granted Apr 26, 2022·8 cites·20 claims
- 0295US9217040B2Therapeutic antibodies against ROR-1 protein and methods for use of sameKIPPS THOMAS J·Filed 2012·Granted Dec 22, 2015·39 cites·9 claims
- 0395US7928213B2Nucleic acids encoding chimeric CD154 polypeptidesUNIV CALIFORNIA·Filed 2009·Granted Apr 19, 2011·35 cites·17 claims
- 0493US9933434B2Therapeutic antibodies against ROR-1 protein and methods for use of sameUNIV CALIFORNIA·Filed 2016·Granted Apr 3, 2018·12 cites·11 claims
- 0593US7495090B2Nucleic acids encoding chimeric CD154 polypeptidesUNIV CALIFORNIA·Filed 2002·Granted Feb 24, 2009·45 cites·17 claims
- 0692US9938350B2Receptor tyrosine kinase-like orphan receptor 1 (ROR1) single chain Fv antibody fragment conjugates and methods of use thereofUNIV CALIFORNIA·Filed 2015·Granted Apr 10, 2018·15 cites·4 claims
- 0792US9758591B2Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasisUNIV CALIFORNIA·Filed 2013·Granted Sep 12, 2017·16 cites·8 claims
- 0891US10900973B2Therapeutic antibodies against ROR-1 protein and methods for use of sameUNIV CALIFORNIA·Filed 2020·Granted Jan 26, 2021·2 cites·8 claims
- 0991US9242014B2Receptor tyrosine kinase-like orphan receptor 1 (ROR1) single chain Fv antibody fragment conjugates and methods of use thereofKIPPS THOMAS J·Filed 2011·Granted Jan 26, 2016·28 cites·1 claims
- 1091US8212009B2Methods and compounds for lymphoma cell detection and isolationKIPPS THOMAS J·Filed 2009·Granted Jul 3, 2012·29 cites·9 claims
- 1190US9523695B2Therapeutic antibodies against ROR-1 protein and methods for use of sameUNIV CALIFORNIA·Filed 2015·Granted Dec 20, 2016·7 cites·12 claims
- 1289US7786282B2Nucleic acid molecules encoding TNF-α ligand polypeptides having a CD154 domainUNIV CALIFORNIA·Filed 2001·Granted Aug 31, 2010·17 cites·24 claims
- 1388US11536727B2Therapeutic antibodies against ROR-1 protein and methods for use of sameUNIV CALIFORNIA·Filed 2020·Granted Dec 27, 2022·1 cites·7 claims
- 1487US10627409B2Therapeutic antibodies against ROR-1 protein and methods for use of sameUNIV CALIFORNIA·Filed 2018·Granted Apr 21, 2020·4 cites·9 claims
- 1587US2025282888A1Antibodies and vaccines for use in treating ror1 cancers and inhibiting metastasisUNIV CALIFORNIA·Filed 2024·Application pending·0 cites
- 1686US10344096B2Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasisUNIV CALIFORNIA·Filed 2017·Granted Jul 9, 2019·4 cites·22 claims
- 1784US12222355B2Therapeutic antibodies against ROR-1 protein and methods for use of sameUNIV CALIFORNIA·Filed 2022·Granted Feb 11, 2025·0 cites·9 claims
- 1883US10913798B2Modulators of ROR1-ROR2 bindingUNIV CALIFORNIA·Filed 2016·Granted Feb 9, 2021·2 cites·14 claims
- 1983US10688181B2Cancer treatment combinationsUNIV CALIFORNIA·Filed 2017·Granted Jun 23, 2020·2 cites·34 claims
- 2081US9250233B2Methods for detecting antibodiesKIPPS THOMAS J·Filed 2009·Granted Feb 2, 2016·7 cites·28 claims
- 2181US7524944B2Chimeric nucleic acids encoding polypeptides comprising CD154 and TNF-αUNIV CALIFORNIA·Filed 2004·Granted Apr 28, 2009·6 cites·9 claims
- 2280US12162950B2Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasisUNIV CALIFORNIA·Filed 2022·Granted Dec 10, 2024·0 cites·14 claims
- 2376US7906638B2Chimeric nucleic acids encoding polypeptides comprising CD70 and Fas ligand domainsUNIV CALIFORNIA·Filed 2009·Granted Mar 15, 2011·1 cites·24 claims
- 2475US2024115700A1Cancer treatment combinationsUNIV CALIFORNIA·Filed 2023·Application pending·0 cites
- 2574US8138310B2Chimeric CD154 polypeptidesPRUSSAK CHARLES E·Filed 2011·Granted Mar 20, 2012·2 cites·2 claims
- 2673US10359432B2Methods for detecting antibodiesUNIV CALIFORNIA·Filed 2015·Granted Jul 23, 2019·1 cites·17 claims
- 2772US6287569B1Vaccines with enhanced intracellular processingUNIV CALIFORNIA·Filed 1998·Granted Sep 11, 2001·55 cites·7 claims
- 2871US7964712B2Chimeric nucleic acids encoding polypeptides comprising TNF alpha, CD70 and FAS ligand domainsUNIV CALIFORNIA·Filed 2010·Granted Jun 21, 2011·1 cites·26 claims
- 2970US11548953B2Receptor tyrosine kinase-like orphan receptor 1 (ROR1) single chain Fv antibody fragment conjugates and methods of use thereofUNIV CALIFORNIA·Filed 2020·Granted Jan 10, 2023·0 cites·10 claims
- 3069US12286480B2Modulators of ROR1-ROR2 bindingUNIV CALIFORNIA·Filed 2020·Granted Apr 29, 2025·0 cites·17 claims
- 3169US10921329B2Methods for detecting antibodiesUNIV CALIFORNIA·Filed 2019·Granted Feb 16, 2021·0 cites·17 claims
- 3268US11654193B2Cancer treatment combinationsUNIV CALIFORNIA·Filed 2020·Granted May 23, 2023·0 cites·13 claims
- 3366US7070771B1Methods of expressing chimeric mouse and human CD40 ligand in human CD40+ cellsUNIV CALIFORNIA·Filed 1997·Granted Jul 4, 2006·13 cites·15 claims
- 3460US2025027945A1Anti-related-to-receptor tyrosine kinase (ryk) antibodies and uses thereofUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 3560US2018362657A1Receptor tyrosine kinase-like orphan receptor 1 (ror1) single chain fv antibody fragment conjugates and methods of use thereofUNIV CALIFORNIA·Filed 2018·Application pending·0 cites
- 3659US2024117047A1Monoclonal antibodies specific for human ror1UNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 3758US7846664B2Diagnosis and treatment of chronic lymphocytic leukemia (CLL)UNIV CALIFORNIA·Filed 2006·Granted Dec 7, 2010·0 cites·13 claims
- 3857US12441791B2Antibodies for treating malignant tumors and uses thereofUNIV SHENZHEN·Filed 2021·Granted Oct 14, 2025·0 cites·18 claims
- 3955US2011190157A1Biomarkers for Diagnosis and Treatment of Chronic Lymphocytic LeukemiaUNIV CALIFORNIA·Filed 2009·Application pending·0 cites
- 4055US2007207510A1Methods and compounds for lymphoma cell detection and isolationUNIV CALIFORNIA·Filed 2007·Application pending·0 cites
- 4153US2023192846A1Anti-ror-2 antibodies and methods of useUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 4251US2023312708A1Chimeric antigen receptor modified t-cells (car-t) for the treatment of hematological and solid tumor cancersUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 4347US2021388086A1Antibodies for detecting various tumor cells and uses thereofUNIV SHENZHEN·Filed 2021·Application pending·0 cites
- 4446US11883492B2Combination treatment of chemoresistant cancersUNIV CALIFORNIA·Filed 2019·Granted Jan 30, 2024·0 cites·15 claims
- 4546US2009304674A1Methods for treating disease by regulating cll cell survivalKIPPS THOMAS J·Filed 2006·Application pending·0 cites
- 4645US2012116052A1Nucleic Acid Molecules Encoding TNF-Alpha Ligand Polypeptides Having a CD154 DomainPRUSSAK CHARLES E·Filed 2011·Application pending·0 cites
- 4744US8114590B2Diagnosis and treatment of chronic lymphocytic leukemia (CLL)INSEL PAUL A·Filed 2010·Granted Feb 14, 2012·0 cites·10 claims
- 4841US2014308301A1Cd44 monoclonal antibody for the treatment of b-cell chronic lymphocytic leukemia and other hematological malignanciesUNIV CALIFORNIA·Filed 2012·Application pending·0 cites
- 4936US2007243561A1Prognostic markers in chronic lymphocytic leukemiaGEERAERTS BEN·Filed 2007·Application pending·0 cites
- 5036US2008280878A1Methods and Compositions for Treating Chronic Lymphocytic LeukemiaCASTRO JANUARIO E·Filed 2005·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →